[ad_1] Marten Bjork Text size Twitter has achieved a "miracle" over the past year by improving the monetization of its platform and achieving GAAP profitability, despite Facebook competition. But MoffettNathanson analyst Michael …
Read More »Snap Stock reaches a new low; Analyst says he is "short of money quickly"
[ad_1] UPDATE with closing price: The shares of Snapchat, parent company of Snap Inc., plunged after a harsh report written by a Wall Street analyst, who warned that the company "was running …
Read More »Tilray share price target raised to more than 10 times the stock market listing price at Cowen
[ad_1] Tilray Inc. & # 39; s TLRY, -7.84% Cowen & Co. has almost tripled its stock price target to reach more than 10 times the price of the initial public offering …
Read More »Tesla on the road to profitability this year and 70% stock gain: analyst
[ad_1] Beck Diefenbach | Reuters Elon Musk, CEO of Tesla. Macquarie Research started Tesla's hedge with outperformance, claiming that the shares of the electric carmaker could appear to be more than 70%.
Read More »Aurora Cannabis seeks to list its shares on the New York Stock Exchange
[ad_1] EDMONTON – The marijuana company Aurora Cannabis Inc. has applied for listing of its shares on the New York Stock Exchange. The shares are expected to trade in New York under …
Read More »Stock futures drop and S & P should record a fourth consecutive decline as bond yields rise
[ad_1] US stock index futures tumbled on Tuesday, suggesting that the recent stock market retreat was about to continue as investors continued to be concerned about rising bond yields and their possible …
Read More »Tesla Stock booming after the deal with the SEC. The Elk Musk tweets cut to $ 10 billion
[ad_1] Tesla Inc. just does not get to take a break. If the defeat triggered by a SEC investigation into CEO Elon Musk's tweets about the automaker's privatization was not enough, a …
Read More »Why stock investors should closely monitor bond yields
[ad_1] Bearish timing of the markets is never easy, but it is even more the case with fixed income securities.
Read More »Impaired stock plunges as cancer drug studies are suspended after death
[ad_1] Affimed NV AFMD, + 10.77% The stock plunged late Monday night after a brief halt, the biotech drug developer having suspended two clinical trials after the death of one participant. Shares …
Read More »Dow is ready for a third consecutive decline as the stock market resumes its yield-driven downturn
[ad_1] US stocks fell on Monday morning, leaving the leading benchmark index down for the third time in a row, as fears of a rapid rate hike overshadowed solid earnings expectations for …
Read More »